Executive summary
Hepatitis B (HBV) is often asymptomatic until late disease. Primary care priorities are: (1) identify who needs testing, (2) use a minimum serology set to interpret status, (3) vaccinate susceptible people at risk, and (4) refer all HBsAg-positive people for specialist assessment and long-term monitoring.
Who to test (common GP triggers)
- Born/raised in intermediate/high prevalence countries; people with household/sexual exposure risk.
- Current/past injecting drug use (including image/performance-enhancing drug injection).
- Men who have sex with men; sex work; multiple sexual partners; sexual assault.
- People in prison, homelessness, or where blood-borne virus prevalence is higher.
- Pregnancy (via antenatal screening, but GPs may encounter results).
- Before immunosuppression (biologics, chemotherapy) or if unexplained LFT abnormalities with risk factors.
Testing and quick interpretation (practical)
Initial test set (minimum): HBsAg and anti-HBc (total/core antibody). Add anti-HBs for immune/vaccine status.
- HBsAg positive → current infection (acute or chronic). Refer for specialist work-up and monitoring.
- HBsAg negative + anti-HBc positive → previous exposure; add anti-HBs (immune) and consider reactivation risk if immunosuppressed.
- HBsAg negative + anti-HBc negative + anti-HBs positive → vaccinated immunity.
- All negative → susceptible; offer vaccination if at risk.
If HBsAg positive, specialist pathways typically request HBeAg/anti-HBe, HBV DNA, LFTs, FBC/platelets, clotting, and co-infection screen (HCV/HDV/HIV), plus liver imaging per guidance.
Vaccination + referral (including pregnancy)
- Vaccination: offer to people at increased risk (use UKHSA Green Book schedules and local commissioning routes).
- Pregnancy: HBsAg-positive pregnant women require specialist assessment promptly to plan third-trimester antiviral treatment where indicated and neonatal prophylaxis.
- Urgent referral: suspected acute severe hepatitis, decompensated liver disease (ascites, encephalopathy, GI bleed), or jaundice with systemic illness.
FAQ
Transparency
This page is an educational, clinician-written summary of publicly available NICE guidance intended for trained healthcare professionals. It uses original wording (not copied text) and should be used alongside the full NICE source, local pathways, and clinical judgement. Doses provided are for general reference; always check the BNF/SPC.